Biomarkers
View abstract on PubMed
Summary
This summary is machine-generated.A novel speech-based method using Pinyin sequences and acoustic features improves Alzheimer's disease detection in Chinese. This approach offers a non-invasive and efficient tool for early cognitive impairment screening.
Area Of Science
- Computational linguistics
- Biomedical engineering
- Neuroscience
Background
- Alzheimer's disease (AD) diagnosis relies on invasive and costly methods, limiting early detection.
- Speech analysis offers a non-invasive alternative for cognitive impairment detection.
- Chinese homophones pose transcription challenges, potentially reducing speech-based model accuracy.
Purpose Of The Study
- To develop and validate a novel speech-based method for improved Alzheimer's disease detection in Chinese speakers.
- To overcome transcription ambiguities caused by homophones by utilizing Pinyin sequences.
- To enhance the efficiency and accuracy of early cognitive impairment screening.
Main Methods
- Utilized audio data from 300 participants in the China Preclinical Alzheimer's Disease Study (C-PAS) cohort.
- Transcribed speech to Pinyin sequences and extracted acoustic features (e.g., pause frequency, MFCCs).
- Employed a Bi-directional LSTM model to integrate Pinyin sequences, acoustic features, and demographic data, incorporating data augmentation techniques.
Main Results
- The proposed method achieved 93.80% accuracy and an AUC of 0.93.
- Integrating Pinyin sequences with acoustic features significantly outperformed models using only acoustic data or cognitive scores.
- Ablation studies confirmed the importance of combining linguistic (Pinyin) and acoustic features.
Conclusions
- Integrating Pinyin sequences and acoustic features is a feasible and effective strategy for non-invasive Alzheimer's detection in Chinese.
- This approach provides a practical tool for early Alzheimer's screening.
- Findings support further large-scale studies and potential clinical applications for cognitive impairment detection.
Related Concept Videos
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

